Trial Profile
Phase I trial of Mariel Therapeutics' eptotermin alfa (BMP-7) in patients with chronic kidney disease
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 20 Oct 2014
Price :
$35
*
At a glance
- Drugs Eptotermin alfa (Primary)
- Indications Renal failure
- Focus Therapeutic Use
- Sponsors Mariel Therapeutics
- 20 Oct 2014 New trial record